Pfizer/BioNTech lead new booster shot rollout amid supply issues for Moderna

Sep. 21, 2022 7:14 AM ETPfizer Inc. (PFE)CVS, CTLT, WBA, MRNA, BNTXBy: Dulan Lokuwithana, SA News Editor18 Comments

Covid-19 Omicron Variant concept


The U.S. government has made available more than 25M doses of updated COVID-19 booster shots, mostly from Pfizer (NYSE:PFE)/BioNTech (BNTX), while Moderna (MRNA) is ramping up production, a federal health agency announced.

Leading pharmacy retailers Walgreens Boots Alliance

Recommended For You

Comments (18)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.